Impact of clonal competition for peptide-MHC complexes on the CD8+ T-cell repertoire selection in a persistent viral infection by Katherine K. Wynn, Zara.

Slides:



Advertisements
Similar presentations
Volume 17, Issue 9, Pages (September 2015)
Advertisements

Molecular Therapy - Methods & Clinical Development
T-cell responses associated with neonatal alloimmune thrombocytopenia: isolation of HPA-1a–specific, HLA-DRB3*0101–restricted CD4+ T cells by Maria Therese.
WT1-specific T-cell responses in high-risk multiple myeloma patients undergoing allogeneic T cell–depleted hematopoietic stem cell transplantation and.
Volume 19, Issue 12, Pages (December 2011)
Tissue Homing and Persistence of Defined Antigen-Specific CD8+ Tumor-Reactive T- Cell Clones in Long-Term Melanoma Survivors  Frédérique-Anne Le Gal, Valérie.
In Vivo Tropism of Hepatitis C Virus Genomic Sequences in Hematopoietic Cells: Influence of Viral Load, Viral Genotype, and Cell Phenotype by Hervé Lerat,
Oligoclonal expansion of T lymphocytes with multiple second-site mutations leads to Omenn syndrome in a patient with RAG1-deficient severe combined immunodeficiency.
Human CD1c+ dendritic cells secrete high levels of IL-12 and potently prime cytotoxic T-cell responses by Giulia Nizzoli, Jana Krietsch, Anja Weick, Svenja.
Idiotype Vaccination in Human Myeloma: Generation of Tumor-Specific Immune Responses After High-Dose Chemotherapy by Massimo Massaia, Paolo Borrione, Silvano.
Functionally Active HIV-Specific T Cells that Target Gag and Nef Can Be Expanded from Virus-Naïve Donors and Target a Range of Viral Epitopes: Implications.
TCL1: a shared tumor-associated antigen for immunotherapy against B-cell lymphomas by Jinsheng Weng, Seema Rawal, Fuliang Chu, Hyun Jun Park, Rakesh Sharma,
Maintenance of HCV-specific T-cell responses in antibody-deficient patients a decade after early therapy by Nasser Semmo, Michaela Lucas, George Krashias,
Epstein-Barr virus–specific human T lymphocytes expressing antitumor chimeric T-cell receptors: potential for improved immunotherapy by Claudia Rossig,
Long-term expansion of effector/memory Vδ2− γδ T cells is a specific blood signature of CMV infection by Vincent Pitard, David Roumanes, Xavier Lafarge,
Ex vivo induction of multiple myeloma–specific cytotoxic T lymphocytes
Macrophages from C3-deficient mice have impaired potency to stimulate alloreactive T cells by Wuding Zhou, Hetal Patel, Ke Li, Qi Peng, Marie-Bernadette.
Rapid generation of combined CMV-specific CD4+ and CD8+ T-cell lines for adoptive transfer into recipients of allogeneic stem cell transplants by Georg.
Volume 8, Issue 2, Pages (February 1998)
CD8+ cytotoxic T lymphocytes isolated from allogeneic healthy donors recognize HLA class Ia/Ib–associated renal carcinoma antigens with ubiquitous or restricted.
CpG oligodeoxynucleotides allow for effective adoptive T-cell therapy in chronic retroviral infection by Anke R. M. Kraft, Frank Krux, Simone Schimmer,
Antigen Presenting Phenotype of Hodgkin Reed-Sternberg Cells: Analysis of the HLA Class I Processing Pathway and the Effects of Interleukin-10 on Epstein-Barr.
Expression of LAG-3 by tumor-infiltrating lymphocytes is coincident with the suppression of latent membrane antigen–specific CD8+ T-cell function in Hodgkin.
Lentivirus-transduced human monocyte-derived dendritic cells efficiently stimulate antigen-specific cytotoxic T lymphocytes by Julie Dyall, Jean-Baptiste.
Mature dendritic cells pulsed with freeze–thaw cell lysates define an effective in vitro vaccine designed to elicit EBV-specific CD4+ and CD8+ T lymphocyte.
by Éric Aubin, Réal Lemieux, and Renée Bazin
Preactivation with IL-12, IL-15, and IL-18 Induces CD25 and a Functional High-Affinity IL-2 Receptor on Human Cytokine-Induced Memory-like Natural Killer.
Asymptomatic primary Epstein-Barr virus infection occurs in the absence of blood T-cell repertoire perturbations despite high levels of systemic viral.
Longitudinal dynamics of antigen-specific CD8+cytotoxic T lymphocytes following primary Epstein-Barr virus infection by Mandvi Bharadwaj, Scott R. Burrows,
Preformed CD40 ligand exists in secretory lysosomes in effector and memory CD4+ T cells and is quickly expressed on the cell surface in an antigen-specific.
Multiple myeloma–reactive T cells recognize an activation-induced minor histocompatibility antigen encoded by the ATP-dependent interferon-responsive (ADIR)
Immunotherapy with Donor T Cells Sensitized with Overlapping Pentadecapeptides for Treatment of Persistent Cytomegalovirus Infection or Viremia  Guenther.
Cytomegalovirus-specific T cells are primed early after cord blood transplant but fail to control virus in vivo by Suzanne M. McGoldrick, Marie E. Bleakley,
by Vladia Monsurrò, Ena Wang, Yoshisha Yamano, Stephen A
T-Cell Receptor Repertoire and Cytokine Pattern in Granuloma Annulare: Defining a Particular Type of Cutaneous Granulomatous Inflammation  Martin Mempel,
CD11c+ dendritic cells and plasmacytoid DCs are activated by human cytomegalovirus and retain efficient T cell-stimulatory capability upon infection by.
Volume 8, Issue 5, Pages (May 1998)
Volume 17, Issue 9, Pages (September 2009)
Mutated regions of nucleophosmin 1 elicit both CD4+ and CD8+ T-cell responses in patients with acute myeloid leukemia by Jochen Greiner, Yoko Ono, Susanne.
Volume 7, Issue 1, Pages (July 1997)
Oxypurinol-Specific T Cells Possess Preferential TCR Clonotypes and Express Granulysin in Allopurinol-Induced Severe Cutaneous Adverse Reactions  Wen-Hung.
Application of the ELISPOT assay to the characterization of CD8+ responses to Epstein-Barr virus antigens by Jie Yang, Victor M. Lemas, Ian W. Flinn, Chris.
J. Joseph Melenhorst, Phillip Scheinberg, Ann Williams, David R
Volume 42, Issue 3, Pages (March 2015)
The absence of ADCC by nivolumab in vitro.
Volume 144, Issue 2, Pages (February 2013)
Volume 143, Issue 1, Pages e3 (July 2012)
Volume 127, Issue 3, Pages (September 2004)
Volume 117, Issue 6, Pages (December 1999)
Tissue Homing and Persistence of Defined Antigen-Specific CD8+ Tumor-Reactive T- Cell Clones in Long-Term Melanoma Survivors  Frédérique-Anne Le Gal, Valérie.
A comparison of gene transfer and antigen-loaded dendritic cells for the generation of CD4+ and CD8+ cytomegalovirus-specific T cells in HLA-A2+ and HLA-A2−
Volume 15, Issue 6, Pages (December 2001)
Immunopathology in RSV Infection Is Mediated by a Discrete Oligoclonal Subset of Antigen-Specific CD4+ T Cells  Steven M Varga, Xiaoting Wang, Raymond.
Cécile Bouneaud, Philippe Kourilsky, Philippe Bousso  Immunity 
Volume 12, Issue 2, Pages (February 2000)
Louise J. McHeyzer-Williams, Michael G. McHeyzer-Williams  Immunity 
by Wanqiu Hou, James S. Gibbs, Xiuju Lu, Christopher B
T Cell Allorecognition via Molecular Mimicry
The Shaping of T Cell Receptor Recognition by Self-Tolerance
Effects of a Single Escape Mutation on T Cell and HIV-1 Co-adaptation
Volume 20, Issue 3, Pages (March 2012)
Molecular Therapy - Oncolytics
Dissecting the Multifactorial Causes of Immunodominance in Class I–Restricted T Cell Responses to Viruses  Weisan Chen, Luis C. Antón, Jack R. Bennink,
Volume 21, Issue 4, Pages (April 2013)
Volume 9, Issue 2, Pages (August 1998)
pDCs from the melanoma environment responded to TLR-L stimulation.
Volume 115, Issue 4, Pages (October 1998)
ALT-803 stimulates proliferation and activation of human NK cells and T cells in vitro. ALT-803 stimulates proliferation and activation of human NK cells.
Supplementary Figure 1 A B C D r2 = 0.15
Volume 15, Issue 6, Pages (December 2001)
Presentation transcript:

Impact of clonal competition for peptide-MHC complexes on the CD8+ T-cell repertoire selection in a persistent viral infection by Katherine K. Wynn, Zara Fulton, Leanne Cooper, Sharon L. Silins, Stephanie Gras, Julia K. Archbold, Fleur E. Tynan, John J. Miles, James McCluskey, Scott R. Burrows, Jamie Rossjohn, and Rajiv Khanna Blood Volume 111(8):4283-4292 April 15, 2008 ©2008 by American Society of Hematology

The HCMV-encoded CD8+ T-cell epitopes CPS and FPT are exclusively recognized by HLA B*3508 individuals. The HCMV-encoded CD8+ T-cell epitopes CPS and FPT are exclusively recognized by HLA B*3508 individuals. (A) Healthy HCMV seropositive donors (shown as D1-D8) who expressed different HLA B35 subtypes were assessed for CPS- and FPT-specific T-cell responses using ELISPOT assays as described in “Methods.” The results are expressed as spot forming cells (SFC) per 106 PBMC. (B) In vitro stimulation of T cells with CPS and FPT epitopes confirmed effector-memory responses exclusively in HLA B*3508 individuals. Polyclonal CTL cultures were generated from 2 HLA-B*3508+ and 3 HLA-B3501+ healthy HCMV-exposed individuals by stimulation with CPS or FPT peptide epitopes. CTLs were tested as effectors at a range of E:T ratios for recognition of autologous phytohemagglutinin (PHA) blast target cells pretreated with the peptide used to stimulate the CTLs or left untreated. The HLA-A/B types of the donors were as follows: donor 1: HLA A2, A2, B*3508, B57; donor 2: HLA A23, A32, B*3508, B49; donor 3: HLA A1, A3, B8, B*3501; donor 4: HLA A11, A32, B*3501, B44, and donor 5: HLA A11, A24, B*3501, B60. Katherine K. Wynn et al. Blood 2008;111:4283-4292 ©2008 by American Society of Hematology

Ex vivo analysis of TRBV usage by CPS- and FPT-specific T cells. Ex vivo analysis of TRBV usage by CPS- and FPT-specific T cells. PBMCs from healthy virus carriers were co-stained with pMHC pentamers (CPS or FPT) and a panel of TRBV monoclonal antibodies. Data based on fresh PBMCs is presented in panels A and B (for CPS-specific T cells) and panels C and D (for FPT-specific T cells). After in vitro culture these T cells were re-analyzed using pMHC-pentamers and a panel of TRBV monoclonal antibodies. Data for CPS-specific T-cell cultures is presented in panels E and F, while data for FPT-specific T cells is displayed in panels G and H. The results are expressed as percent pMHC-pentamer-specific cells. Data presented in panels A, C, E, and G are from donor 1; data in panel B and D are from donor 2; while data in panels F and H are from donor 6 (HLA A30, A32, B*3508, B42). Katherine K. Wynn et al. Blood 2008;111:4283-4292 ©2008 by American Society of Hematology

Immunoscope analysis of the CDR3 region of TCR specific for CPS- and FPT-specific T cells. cDNA samples from PBMCs or in vitro–expanded T cells cultures were used for PCR reaction with Vβ specific primers as outlined in “Methods,” and results were analyzed ... Immunoscope analysis of the CDR3 region of TCR specific for CPS- and FPT-specific T cells. cDNA samples from PBMCs or in vitro–expanded T cells cultures were used for PCR reaction with Vβ specific primers as outlined in “Methods,” and results were analyzed using ABI PRISM GeneScan software. Panel A shows the representative immunoscope profile of CPS-specific CD8+ T cells sorted from fresh PBMCs using pMHC-peptide pentamer; panels B and C show data based on in vitro–expanded T-cell lines. Data in panel A was obtained from donor 2, while data in panels B and C was acquired from donors 1 and 2, respectively. Panel D shows representative data for FPT-specific T cells sorted from fresh PBMCs using pMHC-peptide pentamer; panels E-I show data based on in vitro–cultured T-cell lines. Data presented in panels D and E are from donor 1; data in panels F-H were from donor 2; while data in panel I was from donor 6, respectively. Panel J shows a comprehensive summary of multiple CDR3 profiles for CPS- and FPT-specific T cells. Data presented in panel J is based on the analysis carried out in 3 different HLA B*3508 + individuals. Katherine K. Wynn et al. Blood 2008;111:4283-4292 ©2008 by American Society of Hematology

Nucleotide and amino acid sequences of the CDR3 regions of the TRBV and TRAV chains expressed by CPS- (A) and FPT- (B) specific T cells. Nucleotide and amino acid sequences of the CDR3 regions of the TRBV and TRAV chains expressed by CPS- (A) and FPT- (B) specific T cells. Data presented in this Figure is based on either clonal or pMHC-pentamer sorted CPS- and FPT-specific T cells from fresh PBMCs or polyclonal T-cell lines (as indicated in left-hand column). Sequences from pMHC-pentamer sorted cells were carried out using pooled cells from an individual donor. *Donor 2 PBMCs were used for TRBV sequencing only. Katherine K. Wynn et al. Blood 2008;111:4283-4292 ©2008 by American Society of Hematology

Crystal structures of HLA B*3508CPS and HLA B*3508FPT. Crystal structures of HLA B*3508CPS and HLA B*3508FPT. Panels A and C showing the electron density 2mfo-Dfc at 1σ of the FPT (orange stick) or CPS (purple stick) epitope bound to HLA B*3508. Panel B represents the structures of the featureless FPT peptide (orange) superposed with the one of the bludged CPS epitope (purple), which made one helix turn in its c-terminus. Panels D and E show surface view of the CPS and FPT epitopes bound to the HLA B*3508 molecule. The solvent-exposed surface of the peptide, which is accessible to the TCR, is represented by the green surface. The FPT epitope (panel E) has a smaller solvent-exposed surface than the CPS epitope (panel D). Katherine K. Wynn et al. Blood 2008;111:4283-4292 ©2008 by American Society of Hematology

CD8+ T-cell recognition of target cells sensitized with CPS or FPT epitopes using either viral infection or synthetic peptides. CD8+ T-cell recognition of target cells sensitized with CPS or FPT epitopes using either viral infection or synthetic peptides. (A) MRC-5 cells expressing HLA B*3508 were infected with HCMV at an MOI of 5:1 and then exposed to CPS- or FPT-specific T cells (responder to stimulator ratio of 2:1) at different time intervals (indicated on x-axis). At each time point, T cells were assessed for IFN-γ expression using intracellular cytokine assay. Data presented here is summary of 3 different experiments based on 3 different HLA B*3508+ donors. (B) CTL recognition of HLA B*3508 expressing target cells sensitized with synthetic CPS and FPT peptide epitopes. MRC-5 cells expressing HLA B*3508 were sensitized with serial dilutions of the peptides and then exposed to CPS- or FPT-specific CTL lines. These clonal T cells were derived from donor 1. (C) MRC-5 cells expressing HLA B*3508 were sensitized with synthetic CPS- or FPT-peptide epitopes (1 μg/mL) and then exposed to CPS- or FPT-specific T cells (responder to stimulator ratio of 2:1) for 16 to 18 hours. T cells were assessed for IFN-γ expression using intracellular cytokine assay. Data presented here is a summary of 3 different experiments. (D) HCMV-infected MRC-5 cells expressing either wild-type or mutated (to disallow CD8 co-receptor binding) HLA*B3508 were exposed to CPS- or FPT-specific T cells at 2 different responder-to-stimulator ratios, and IFN-γ expression measured using an intracellular cytokine assay. These data are representative of 3 different experiments and shows mean fluorescence intensity (MFI) of IFN-γ expression in CPS- or FPT-specific T cells. (E) MRC-5 cells expressing HLA B*3508 were pre-sensitized with synthetic peptide epitopes (CPS or FPT) and then exposed to CPS- or FPT-specific T cells (responder to stimulator ratio of 2:1). These T cells were assessed for IFN-γ expression as described above. MFI indicates mean fluorescence intensity. Katherine K. Wynn et al. Blood 2008;111:4283-4292 ©2008 by American Society of Hematology

Ex vivo phenotypic analysis of CPS- and FPT-specific T cells. Ex vivo phenotypic analysis of CPS- and FPT-specific T cells. Panel A: PBMC from HCMV-infected healthy individual were co-stained with pMHC-pentamers and antibodies specific for CD27, CD57 and CD62L. Data presented here is a summary of 3 different experiments. Panel B: To determine any functional differences between CPS and FPT-specific T cells, these effector cells were exposed to MRC-5 cells expressing HLA B*3508 and co-infected with HCMV at an MOI of 0.5:1. 2 different responder to stimulator ratios (80:1 and 20:1) were used in these assays. Following incubation, these cells were co-stained with pMHC pentamer, anti-IFN-γ and anti-CD107a as outlined in the Material and Methods section. This data are representative of 3 different experiments. Katherine K. Wynn et al. Blood 2008;111:4283-4292 ©2008 by American Society of Hematology